Cadrenal Therapeutics, Inc. (CVKD) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $2.74M | -63.2% |
| 2024 | $7.44M | -3.3% |
| 2023 | $7.69M | +238.6% |
| 2022 | -$5.55M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $2.74M | -63.2% |
| 2024 | $7.44M | -3.3% |
| 2023 | $7.69M | +238.6% |
| 2022 | -$5.55M | — |